Sector Review: Action in the Healthcare Sector on Dec 15th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • ZOLL Medical Corporation (NASDAQ:ZOLL): The shares closed at $60.29, up $13.46, or 28.74%, on the day. Its market capitalization is $1.34 billion. About the company: Zoll Medical Corporation designs, manufactures, and markets an integrated line of proprietary, non-invasive resuscitation devices and disposable electrodes. The Company’s products are used by health care professionals to provide pacing and defibrillation. Zoll also designs and markets software that automates collection and management of data for emergency medical service providers. Get the most recent company news and stock data here >>
  • SonoSite, Inc. (NASDAQ:SONO): The shares closed at $53.70, up $11.46, or 27.13%, on the day. Its market capitalization is $748.51 million. About the company: SonoSite, Inc. manufactures hand-held ultrasound imaging equipment. The Company’s equipment is approximately the size of a laptop computer and permits the provision of ultrasound services in places previously not possible. Get the most recent company news and stock data here >>
  • CARDIOME PHARMA CORP (NASDAQ:CRME): The shares closed at $2.15, up $0.28, or 14.97%, on the day. Its market capitalization is $131.43 million. About the company: Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with clinical drug programs. The Company’s programs focus on atrial arrhythmia and congestive heart failure. Get the most recent company news and stock data here >>
  • Alnylam Pharmaceuticals (NASDAQ:ALNY): The shares closed at $7.90, up $0.53, or 7.19%, on the day. Its market capitalization is $337.54 million. About the company: Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes. Get the most recent company news and stock data here >>
  • Accuray Incorporated (NASDAQ:ARAY): The shares closed at $4.17, up $0.26, or 6.65%, on the day. Its market capitalization is $294.04 million. About the company: Accuray Inc. has developed an intelligent robotic radiosurgery system designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. Get the most recent company news and stock data here >>

Losers (% price change)

  • InterMune, Inc. (NASDAQ:ITMN): The shares closed at $12.74, down $5.55, or 30.34%, on the day. Its market capitalization is $834.57 million. About the company: InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease Get the most recent company news and stock data here >>
  • MELA Sciences, Inc. (NASDAQ:MELA): The shares closed at $3.97, down $0.32, or 7.46%, on the day. Its market capitalization is $100.29 million. About the company: MELA Sciences Inc is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company’s product features a device that captures images of suspicious pigmented skin lesions and extracts data. Get the most recent company news and stock data here >>
  • Flamel Tech. S.A. (NASDAQ:FLML): The shares closed at $4.70, down $0.32, or 6.37%, on the day. Its market capitalization is $114.41 million. About the company: Flamel Technologies S.A. develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. The Company’s programs include “Micropump” and “Medusa” in drug delivery, and “ColCys” in biomaterial-based medical devices. Flamel builds on its technology platforms to develop other products, such as new materials for opthalmic lens products. Get the most recent company news and stock data here >>
  • Progenics Pharmaceuticals (NASDAQ:PGNX): The shares closed at $7.06, down $0.47, or 6.24%, on the day. Its market capitalization is $238.36 million. About the company: Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics’ principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology. Get the most recent company news and stock data here >>
  • Amarin Corp. plc (NASDAQ:AMRN): The shares closed at $6.03, down $0.35, or 5.49%, on the day. Its market capitalization is $817.08 million. About the company: Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>